Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.

Pile of papers with bright paperclips © Shutterstock

The living reviews will summarise literature around one topic and are a response to the speed and volume of COVID-19 immunology research published during the pandemic.

On behalf of the Oxford-Cardiff COVID-19 Literature Consortium, Dr Ewoud Compeer, University of Oxford points out the idea behind this new publishing format: "The field of COVID-19 immunology was seeing new developments and new hypotheses appearing at an extreme pace online in the form of pre-prints. This speed of publishing made literature reviews outdated even before a journal published them. Our 'living reviews' will stay "live" for a designated period, being updated as change happens."

The journal publishes peer reviewed scientific articles, and the annotation enables rapid communication of updated information, but the version of record does not change so provides a history of the scientific developments.

Professor Awen Gallimore, Cardiff University finds similar advantages to the 'live' format of reviews: "Because new information emerges day by day, when you publish something on Monday by the following Friday it may already be out of date. Our living reviews enable as-you-go updates and should represent a useful step towards supporting scientists address the big and trending research questions."

The COVID-19 Literature initiative began with a team of around 100 post-doctoral researchers, DPhil students, and faculty members from the Medical Sciences Division at the University of Oxford reading, reviewing and summarising the latest COVID-19 research from all round the world in order to support frontline researchers.

At Cardiff, the School of Medicine-wide Journal Club, also comprising PhD students, post-docs and ECRs had started a similar initiative. Oxford and Cardiff joined forces to pool expertise around a wider range of disciplines and ensure those on the frontline were up to date with the latest developments in the field.

The living reviews add to a growing body of material from the Oxford-Cardiff COVID-19 Literature Consortium that is available through their website, and popular science blog, and could become a new benchmark for reviewing research in the future.

"We are pleased to be able to support the research community with this new series of Living Reviews from the Oxford-Cardiff COVID-19 Literature Consortium. We're excited to be able to offer this new open annotation functionality to our authors in Oxford Open Immunology and hope that this innovative new format will generate a useful and up to date resource for readers," said Rhiannon Meaden, Senior Publisher at OUP.

"The reviews were like a paint-by-numbers, we knew there were bits missing and new colours were coming in week by week, but it would be years before we got the whole picture," said Luke Davies from Cardiff University, one of the authors of the first published review. "A living review allows us to carefully add to the picture over time, while still delivering an up-to-date snapshot of the field that can aid ongoing research."

The first living reviews to be published are: Viral entry, sensing and evasion, and Dysregulated inflammation drives immunopathology.

 

 

Similar stories

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).